Advertisement
News
Subscribe to MDT Magazine News

ViroPharma board approves $150 million buyback

March 9, 2011 8:45 am | by The Associated Press | Comments

ViroPharma Inc. said Wednesday that its board of directors approved a program to buy back up to $150 million in stock and 2 percent senior convertible notes due 2017.The company had about 78.1 million shares of common stock outstanding as of Dec. 31.Shares of ViroPharma rose 99 cents, or 5.5...

AeroDef Sessions to Show How OEMs, Suppliers Are Creating 'Digital Thread'

March 9, 2011 8:35 am | by Society of Manufacturing Engineers | Comments

Anaheim, March 9, 2011 — The concept of a digital thread — several supply chain partners with different skill sets, systems and processes, working together with OEMs to integrate aerospace and defense manufacturing to a greater degree than has ever been accomplished in the...

Abnormal neural activity recorded from the deep brain of Parkinson's disease and dystonia patients

March 9, 2011 7:36 am | by EurekAlert | Comments

(National Institute for Physiological Sciences) An international joint research team led by Professor Toru Itakura and Assistant Professor Hiroki Nishibayashi from Wakayama Medical University, Japan, Professor Atsushi Nambu from the National Institute for Physiological Sciences,...

TOPICS:
Advertisement

High-volume portable music players may impair ability to clearly discriminate sounds

March 9, 2011 7:35 am | by EurekAlert | Comments

(National Institute for Physiological Sciences) The study was a collaboration between Drs. Hidehiko Okamoto and Ryusuke Kakigi from the National Institute for Physiological Sciences, Japan, and Drs. Christo Pantev and Henning Teismann from the University of Muenster. The...

TOPICS:

Reportlinker Adds Advances in SPECT Imaging (Technical Insights)

March 9, 2011 7:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Advances in SPECT Imaging (Technical Insights) http://www.reportlinker.com/p0443053/Advances-in-SPECT-Imaging-Technical-Insights.html This research service evaluates the...

TOPICS:

University of Wisconsin Carbone Cancer Center to Acquire ViewRay Radiation Therapy System

March 9, 2011 7:33 am | by Bio-Medicine.Org | Comments

CLEVELAND, March 9, 2011 /- The University of Wisconsin Carbone Cancer Center (UWCCC) in Madison, Wisconsin, will soon become one of the first oncology research centers to acquire a radiotherapy system from ViewRay™, Inc., a privately held medical device company. ViewRay's new...

TOPICS:

Consumer Information on: Selenia Dimensions 3D System - P080003

March 9, 2011 6:36 am | by U.S. Food & Drug Administration | Comments

The Selenia Dimensions 3D System is comprised of hardware and software upgrades to the Selenia Dimensions 2D full-field digital mammography system, which is FDA approved for conventional mammography. The hardware upgrades produces multiple, low-dose x-ray

Summary Information for: Selenia Dimensions 3D System

March 9, 2011 6:36 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Selenia Dimensions 3D System (P080003).

Advertisement

Hospira Announces U.S. Approval of Generic Docetaxel

March 9, 2011 6:34 am | by Bio-Medicine.Org | Comments

LAKE FOREST, Ill., March 9, 2011 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval of docetaxel. The medication is a generic version of Sanofi-Aventis's Taxotere®, and Hospira...

TOPICS:

Critical Need Exists to Address Health Conditions That Put Patients at Highest Risk for Deep-Vein Thrombosis and Pulmonary Embolism

March 9, 2011 6:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 9, 2011 /- As part of the eighth annual DVT (deep-vein thrombosis) Awareness Month, the Coalition to Prevent DVT is focusing on the importance of DVT and its risk factors among patients with co-morbid conditions – including but not limited to cancer, heart or...

TOPICS:

Endo to Present at the Barclays Capital 2011 GlobalHealthcare Conference

March 9, 2011 6:34 am | by Bio-Medicine.Org | Comments

CHADDS FORD, Pa., March 9, 2011  /- Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that it will present at the Barclays Capital 2011 GlobalHealthcare Conference on Tuesday, March 15, 2011 at 3:45 p.m. ET.  Dr. Ivan Gergel executive vice president of R&D of Endo will...

TOPICS:

Md. delays action on $2.4B prescription drug deal

March 9, 2011 5:45 am | by BRIAN WITTE - Associated Press - Associated Press | Comments

A $2.4 billion contract for a prescription drug plan for Maryland state employees has been pulled from a state board's Wednesday agenda after a company competing for the contract filed its fourth protest about the procurement process.Sheila McDonald, the executive secretary of the Board of...

Medtronic resolves FDA warnings over 2 factories

March 9, 2011 5:45 am | by The Associated Press | Comments

Medtronic Inc., the world's largest medical device company, says it has resolved two warning letters from the Food and Drug Administration over lax oversight at two manufacturing plants, clearing the way for new product approvals.The FDA cited the company in November 2009 and June 2009 over...

Stonewedge still stealthy after second $1M round

March 9, 2011 4:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Andover startup Stonewedge Corp. has taken in $1 million from a single, unnamed investor, bringing to $2 million the amount the stealthy wellness technology company has raised.

Contrast Media Reactions Are Allergic, but Minor

March 9, 2011 4:34 am | by Diagnostic Imaging | Comments

Final results of the prospective French CIRTACI trial are in: contrast media for diagnostic imaging are very safe in general, as long as radiologists are vigilant for patients with allergies, asthma, or previous reactions to contrast agents. The vast majority are more itchy than serious.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading